Beilstein Journal of Organic Chemistry

Beilstein J Org Chem. 14: 1563-1569

Phosphoramidite building blocks with protected nitroxides for the synthesis of spin-labeled DNA and RNA

Timo Weinrich¹, Eva A Jaumann², Ute M Scheffer¹, Thomas F Prisnerhttp://orcid.org/0000-0003-2850-9573², Michael W Göbelhttp://orcid.org/0000-0002-5694-4823¹

Jeroen S Dickschat, Associate Editor

1. Institute of Organic Chemistry and Chemical Biology, Goethe University Frankfurt, Max-von-Laue-Str. 7, D-60438 Frankfurt am Main, Germany

2. Institute of Physical and Theoretical Chemistry, Goethe University Frankfurt, Max-von-Laue-Str. 7, D-60438 Frankfurt am Main, Germany

Copyright © 2018, Weinrich et al.; licensee Beilstein-Institut.

DOI: 10.3762/bjoc.14.133

Published online: 26 June 2018

Abstract

TEMPO spin labels protected with 2-nitrobenzyloxymethyl groups were attached to the amino residues of three different nucleosides: deoxycytidine, deoxyadenosine, and adenosine. The corresponding phosphoramidites could be incorporated by unmodified standard procedures into four different self-complementary DNA and two RNA oligonucleotides. After photochemical removal of the protective group, elimination of formic aldehyde and spontaneous air oxidation, the nitroxide radicals were regenerated in high yield. The resulting spin-labeled palindromic duplexes could be directly investigated by PELDOR spectroscopy without further purification steps. Spin–spin distances measured by PELDOR correspond well to the values obtained from molecular models.

Introduction

EPR spectroscopy is well established to study the structure and dynamics of nucleic acids [1–8]. Although the information attainable by EPR is less detailed when compared to NMR, it is often complementary. While local conformations are normally obtained from NMR data, EPR can measure long distances that are hardly accessible by NMR [9–10]. Furthermore, spin labeling of biopolymers can support NMR studies by paramagnetic relaxation enhancement [11–12]. For nucleic acids, spin labeling is most often achieved by covalent attachment of nitroxides. Unfortunately, the conditions required to assemble oligonucleotides by phosphoramidite chemistry and to ligate them enzymatically, are known to partially degrade nitroxides. This problem can be reduced by postsynthetic introduction of the spin label [13–24]. Starting from convertible nucleotides, for example, nucleophilic displacement by 4-amino-TEMPO has been used to prepare RNA strands containing the cytidine derivative 1 and its adenosine analog 3 [8,25–26] (Fig. 1). Alternatively, by adapting the standard synthetic procedures, nitroxides can be directly incorporated into oligonucleotides by phosphoramidite building blocks [27–40]. However, some degradation of the spin labels inevitably will occur. Nitroxide labeled DNA strands of the general structures 2 and 4 have been prepared by this way [30,34,37].

Figure 1View larger versionFigure 1. Structures of TEMPO-labeled oligonucleotides and of phosphoramidites 5–8.

In recent years, we have therefore developed a third strategy based on photolabile protective groups [41–43] finally leading to phosphoramidite 6. This building block behaves in solid-phase RNA synthesis as any normal TOM protected amidite. It is completely stable against the conditions used for strand assembly, RNA deprotection and enzymatic ligation. Amidite 6 has been applied to synthesize a full-length TAR RNA labeled with two nitroxide precursors. In the last step, the 2-nitrobenzyloxymethyl groups were removed by irradiation at 365 nm. After elimination of formic aldehyde induced by gentle heating, the resulting hydroxylamines spontaneously reacted with air to form the nitroxide radicals in high yield [43]. Although the rigid spin labels introduced by Sigurdsson [31–33], Hopkins [27,29] and Engels [20–21] are generally considered advantageous for EPR studies, TEMPO-modified RNAs according to structures 1 and 3 have been successfully used in PELDOR experiments to determine the distance between two spins [8,25,43]. The apparent usefulness of such building blocks has prompted us in the present study to extend the protection strategy from amidite 6 to its DNA analog 5 and to adenosine derivatives 7 and 8.

Results and Discussion

To prepare compound 5, the deoxyuridine derivative 9 [44] was activated by sulfonylation and then treated with the protected TEMPO building block 10 [43] to provide 11 (Scheme 1). After deacetylation, phosphitylation of 12 straightforwardly led to amidite 5 in multigram amounts. In contrast to the corresponding nitroxide, all NMR spectra of 5 are well resolved indicating the absence of any paramagnetic moiety.

Scheme 1View larger versionScheme 1. Synthesis of phosphoramidite 5. Reagents and conditions: (a) 1. 2,4,6-triisopropylbenzenesulfonyl chloride, Et₃N, 4-dimethylaminopyridine, CH₂Cl₂, 0 °C → rt, 19 h; 2. addition of 10, diisopropylethylamine, DMF, 90 °C, 24 h; (b) MeOH, NaHCO₃, rt, 2.5 h; (c) N,N-diisopropylamino(2-cyanoethyl)phosphoramidic chloride, Et₃N, CH₂Cl₂, rt, 20 h.

Unlike compound 9, the corresponding inosine derivative is known to produce a mixture upon sulfonylation [30], a reaction giving poor yields in our hands. We therefore used the 6-chloro derivative 13 as starting material, easily accessible from deoxyadenosine via enzymatic deamination, acetylation [37] and chlorination. This compound reacted cleanly and yielded 67% of the TEMPO conjugate 14. After deacetylation (15) and tritylation (16), amidite building block 7 was obtained by phosphitylation in ample quantity (Scheme 2).

Scheme 2View larger versionScheme 2. Synthesis of phosphoramidite 7. Reagents and conditions: (a) Addition of 10, diisopropylethylamine, 1-propanol, 75 °C, 8 h, rt, 14 h; (b) 7 N NH₃ in MeOH, 0 °C → rt, 3 h; (c) dimethoxytrityl chloride, pyridine, rt, 23 h; (d) N,N-diisopropylamino(2-cyanoethyl)phosphoramidic chloride, Et₃N, CH₂Cl₂, rt, 4.5 h.

Inosine derivatives protected with TOM in 2’-position are accessible but only by a multistep procedure [45]. We therefore decided to synthesize the corresponding 2’-O-TBS building block instead (Scheme 3). Starting compound 17 was prepared in a similar way as 13 by enzymatic deamination of adenosine, acetylation [46] and chlorination. A clean reaction with amino-TEMPO compound 10 then produced 78% of compound 18. Ester hydrolysis (19) and tritylation afforded 20 which was silylated with 1.8 equiv of TBS chloride. Although the 3’-silylated and bis-silylated side products could be easily removed and converted back to 20, the 35% yield of compound 21 obtained in this step limited the availability of amidite 8 compared to its analogs 5 and 7. Nevertheless, yields of 8 are sufficient to incorporate this type of spin label into RNA strands.

Scheme 3View larger versionScheme 3. Synthesis of phosphoramidite 8. Reagents and conditions: (a) Addition of 10, diisopropylethylamine, 1-propanol, 75 °C, 7 h, rt, 14 h; (b) 7 N NH₃ in MeOH, 0 °C → rt, 3 h; (c) dimethoxytrityl chloride, pyridine, rt, 20 h; (d) tert-butyldimethylsilyl chloride, imidazole, DMF, rt, 22 h; (e) N,N-diisopropylamino(2-cyanoethyl)phosphoramidic chloride, Et₃N, CH₂Cl₂, rt, 23 h.

The phosphoramidite building blocks 5, 7, and 8 have been used to prepare a series of self-complementary DNA (22a–25a) and RNA oligonucleotides (26a, 27a), each containing one protected TEMPO label (Fig. 2). Chain assembly and deprotection proceeded uneventfully (Supporting Information File 1, Figures S1–S3). All oligonucleotides were purified by anion exchange and reversed-phase HPLC and characterized by mass spectrometry (Supporting Information File 1, Figures S4–S9). Upon photochemical deprotection (365 nm), the primary products are the hemiacetals 22b–27b (Supporting Information File 1, Figure S10). They still prevent air oxidation of the hydroxylamines and are removed by gentle heating. In case of the 12mers, clean analytical separation of hemiacetals (22b, 24b, 26b) from nitroxides (22c, 24c, 26c) was possible by RP-HPLC (Supporting Information File 1, Figure S10). The detection of hemiacetals by HPLC became more troublesome for the 18mers. An indirect clue about their existence comes from cw-EPR spectra measured directly after irradiation indicating imperfect reoxidation of the nitroxides (Supporting Information File 1, Figure S20). To form the palindromic duplexes, samples were submitted to an annealing procedure by heating to 90 °C. This step also completes the conversion of hemiacetals into nitroxide radicals 22c–27c in all cases. It should be noted, however, that palindromic duplexes may coexist in equilibrium with monomeric hairpin structures (see below). HPLC measurements gave no evidence for the formation of reduction products 22d–27d. Hydrolytic degradation of the oligonucleotides was not observed.

Figure 2View larger versionFigure 2. Structures of palindromic oligonucleotides prepared from amidites 5 (22a, 23a), 7 (24a, 25a), and 8 (26a, 27a). Hemiacetals 22b–27b were obtained after photochemical deprotection (custom built apparatus with three LEDs Nichia NCCU033, 365 nm, each with 100 mW optical output power [41]. 20 min irradiation in 10 mM phosphate buffer, pH 7.4). Subsequent elimination of formic aldehyde and air oxidation transformed these intermediates into nitroxides 22c–27c. Amines 22d–27d, typical degradation products of nitroxides, could not be detected.

For successful PELDOR experiments the quality of spin labeled samples is essential. We have shown previously that RNA strands synthesized from amidite 6 are ready for PELDOR studies directly after photochemical deprotection and annealing [43]. No further purification is required. In the same way we have now treated all oligonucleotides 22a–27a. Each strand was irradiated in buffer solution at 365 nm and then heated to 90 °C for 70 min and slowly cooled down for duplex formation and decay of hemiacetals (Supporting Information File 1, Table S1). The samples were subsequently measured without additional treatment. Fig. 3 shows an example for the PELDOR distance measurements conducted for all doubly labeled palindromes 22c–27c. Like for all samples, 24c shows a clear oscillation in the time trace and a well-defined distance. The results for all PELDOR measurements are shown in Figure S21 (Supporting Information File 1). The experimental distances are summarized in Table 1 and coincide well with values predicted from modelling. However, although the degree of spin labeling was very high in all cases, large variations in modulation depth are visible (Supporting Information File 1, Figure S21). This effect can be explained by conformational equilibria between palindromic dimers and monomeric hairpin structures lacking a second TEMPO label. Analysis by NUPACK [47] predicts RNA 18mer 27c to exist exclusively in form of the duplex while DNA 18mers 23c and 25c should also form the monomeric hairpin structures. This prediction can be verified by native gel electrophoresis (Supporting Information File 1, Figure S19). Electrophoresis also shows the 12mer RNA 26c to form mainly duplexes while high amounts of monomers are seen with DNA analogs 22c and 24c, in full accord with NUPACK predictions and the experimentally observed levels of modulation depth.

Figure 3View larger versionFigure 3. PELDOR measurement of 24c (12mer dA). The background-corrected time trace (original time trace in Supporting Information File 1, Figure S21) was fitted with Tikhonov regularization (red) with DeerAnalysis15 [48]. The distance distribution shows a well-defined distance of 2.9 ± 0.2 nm.

See full tableTable 1. Spin–spin distances in oligonucleotides 22c–27c determined by PELDOR and by molecular modelling. The predicted distance is an average of N–N, N–O, O–N, and O–O distances.

Conclusion

All three phosphoramidite building blocks 5, 7, and 8 are applicable for automated solid-phase synthesis using standard reaction cycles. As in the case of amidite 6, the 2-nitrobenzyloxymethyl group is stable and does not interfere with work-up and purification. Thus, all oligonucleotides 22a–27a were obtained in good yield and high purity. While photochemical removal of the 2-nitrobenzyl part is fast, care has to be taken to complete the conversion of hemiacetals. After the annealing procedure, mean spin labeling efficiencies of 96% have been found. Samples of similar quality including TEMPO labeled cytidines are also accessible by postsynthetic modification of convertible nucleotides [8,25–26]. However, the analogous reaction forming TEMPO-labeled adenosine tends to be sluggish and incomplete [25]. Furthermore, the protection group present in 22a–27a also shields the nitroxide precursor if subsequent enzymatic ligation steps in thiol containing buffers are required [43]. A single case has been reported earlier of an O-acetyl protected TEMPO moiety attached to a deoxyuridine phosphoramidite by a more flexible chain [49]. This building block also enabled the synthesis of spin labeled DNA strands but required incubation with 0.5 M aqueous NaOH for 24 h for complete release of the nitroxide. Such conditions are not compatible with RNA. Therefore, the use of photolabile protective groups for nitroxides currently provides the most general approach for synthesizing spin labeled DNA and RNA. This strategy looks promising not only for TEMPO but also for other types of nitroxides such as TPA [20–21 27,29] or Ç [31–33].

Supplementary Material

Open In Web Browser

Acknowledgments

Financial support by the Deutsche Forschungsgemeinschaft (DFG) (collaborative research center 902) and the International Max Planck Research School (IMPRS) of the MPI of Biophysics in Frankfurt is gratefully acknowledged.

Articles from Beilstein Journal of Organic Chemistry are provided here courtesy of Beilstein-Institut

PMC Copyright Notice

The articles available from the PMC site are protected by copyright, even though access is free. Copyright is held by the respective authors or publishers who provide these articles to PMC. Users of PMC are responsible for complying with the terms and conditions defined by the copyright holder.

Users should assume that standard copyright protection applies to articles in PMC, unless an article contains an explicit license statement that gives a user additional reuse or redistribution rights. PMC does not allow automated/bulk downloading of articles that have standard copyright protection.

See the copyright notice on the PMC site, https://www.ncbi.nlm.nih.gov/pmc/about/copyright/, for further details and specific exceptions.

References

Haugland M M, Lovett J E, Anderson E A, authors. Chem Soc Rev. 2018;47:668–680. [Cross Ref] [PubMed]

Fielding A J, Concilio M G, Heaven G, Hollas M A, authors. Molecules. 2014;19:16998–17025. [Cross Ref] [PubMed]

Shelke S A, Sigurdsson S T, authors. Eur J Org Chem. 2012;2291–2301. [Cross Ref]

Endeward B, Marko A, Denysenkov V P, Sigurdsson S T, Prisner T F, authors. Methods Enzymol. 2015;564:403–425. [Cross Ref] [PubMed]

Prisner T F, Marko A, Sigurdsson S T, authors. J Magn Reson. 2015;252:187–198. [Cross Ref] [PubMed]

Grytz C M, Kazemi S, Marko A, Cekan P, Güntert P, Sigurdsson S T, Prisner T F, authors. Phys Chem Chem Phys. 2017;19:29801–29811. [Cross Ref] [PubMed]

Stelzl L S, Erlenbach N, Heinz M, Prisner T F, Hummer G, authors. J Am Chem Soc. 2017;139:11674–11677. [Cross Ref] [PubMed]

Halbmair K, Seikowski J, Tkach I, Höbartner C, Sezer D, Bennati M, authors. Chem Sci. 2016;7:3172–3180. [Cross Ref]

Duss O, Diarra dit Konté N, Allain F H-T, authors. Methods Enzymol. 2015;565:537–562. [Cross Ref] [PubMed]

Gmeiner C, Dorn G, Allain F H T, Jeschke G, Yulikov M, authors. Phys Chem Chem Phys. 2017;19:28360–28380. [Cross Ref] [PubMed]

Wunderlich C H, Huber R G, Spitzer R, Liedl K R, Kloiber K, Kreutz C, authors. ACS Chem Biol. 2013;8:2697–2706. [Cross Ref] [PubMed]

Schnorr K A, Gophane D B, Helmling C, Cetiner E, Pasemann K, Fürtig B, Wacker A, Qureshi N S, Gränz M, Barthelmes D, et al., authors. J Biomol NMR. 2017;68:53–63. [Cross Ref] [PubMed]

Kim N-K, Murali A, DeRose V, authors. J Chem Biol. 2004;11:939–948. [Cross Ref]

Saha S, Jagtap A P, Sigurdsson S T, authors. Chem Commun. 2015;51:13142–13145. [Cross Ref]

Qin P Z, Hideg K, Feigon J, Hubbell W L, authors. Biochemistry. 2003;42:6772–6783. [Cross Ref] [PubMed]

Duss O, Michel E, Yulikov M, Schubert M, Jeschke G, Allain F H-T, authors. Nature. 2014;509:588–592. [Cross Ref] [PubMed]

Duss O, Yulikov M, Jeschke G, Allain F H-T, authors. Nat Commun. 2014;5:No. 3669 [Cross Ref]

Esquiaqui J M, Sherman E M, Ye J-D, Fanucci G E, authors. Biochemistry. 2016;55:4295–4305. [Cross Ref] [PubMed]

Zhang X, Tung C-S, Sowa G Z, Hatmal M M, Haworth I S, Qin P Z, authors. J Am Chem Soc. 2012;134:2644–2652. [Cross Ref] [PubMed]

Schiemann O, Piton N, Plackmeyer J, Bode B E, Prisner T F, Engels J W, authors. Nat Protoc. 2007;2:904–923. [Cross Ref] [PubMed]

Krstić I, Hänsel R, Romainczyk O, Engels J W, Dötsch V, Prisner T F, authors. Angew Chem, Int Ed. 2011;50:5070–5074. [Cross Ref]

Ding P, Wunnicke D, Steinhoff H-J, Seela F, authors. Chem – Eur J. 2010;16:14385–14396. [Cross Ref] [PubMed]

Kerzhner M, Abdullin D, Więcek J, Matsuoka H, Hagelueken G, Schiemann O, Famulok M, authors. Chem – Eur J. 2016;22:12113–12121. [Cross Ref] [PubMed]

Haugland M M, El-Sagheer A H, Porter R J, Peña J, Brown T, Anderson E A, Lovett J E, authors. J Am Chem Soc. 2016;138:9069–9072. [Cross Ref] [PubMed]

Sicoli G, Wachowius F, Bennati M, Höbartner C, authors. Angew Chem, Int Ed. 2010;49:6443–6447. [Cross Ref]

Büttner L, Seikowski J, Wawrzyniak K, Ochmann A, Höbartner C, authors. Bioorg Med Chem. 2013;21:6171–6180. [Cross Ref] [PubMed]

Spaltenstein A, Robinson B H, Hopkins P B, authors. J Am Chem Soc. 1988;110:1299–1301. [Cross Ref]

Persichetti R A, Sinden R R, Duh J-L, Bobst A M, authors. Synth Commun. 1991;21:1013–1019. [Cross Ref]

Miller T R, Alley S C, Reese A W, Solomon M S, McCallister W V, Mailer C, Robinson B H, Hopkins P B, authors. J Am Chem Soc. 1995;117:9377–9378. [Cross Ref]

Giordano C, Fratini F, Attanasio D, Cellai L, authors. Synthesis. 2001;565–572. [Cross Ref]

Barhate N, Cekan P, Massey A P, Sigurdsson S T, authors. Angew Chem, Int Ed. 2007;46:2655–2658. [Cross Ref]

Cekan P, Smith A L, Barhate N, Robinson B H, Sigurdsson S T, authors. Nucleic Acids Res. 2008;36:5946–5954. [Cross Ref] [PubMed]

Höbartner C, Sicoli G, Wachowius F, Gophane D B, Sigurdsson S T, authors. J Org Chem. 2012;77:7749–7754. [Cross Ref] [PubMed]

Cekan P, Sigurdsson S T, authors. J Am Chem Soc. 2009;131:18054–18056. [Cross Ref] [PubMed]

Gophane D P, Sigurdsson S T, authors. Chem Commun. 2013;49:999–1001. [Cross Ref]

Gophane D P, Endeward B, Prisner T F, Sigurdsson S T, authors. Chem – Eur J. 2014;20:15913–15919. [Cross Ref] [PubMed]

Gophane D P, Sigurdsson S T, authors. Beilstein J Org Chem. 2015;11:219–227. [Cross Ref] [PubMed]

Gophane D P, Endeward B, Prisner T F, Sigurdsson S T, authors. Org Biomol Chem. 2018;16:816–824. [Cross Ref] [PubMed]

Singh V, Azarkh M, Exner T E, Hartig J S, Drescher M, authors. Angew Chem, Int Ed. 2009;48:9728–9730. [Cross Ref]

Azarkh M, Singh V, Okle O, Seemann I T, Dietrich D R, Hartig J S, Drescher M, authors. Nat Protoc. 2013;8:131–147. [Cross Ref] [PubMed]

Seven I, Weinrich T, Gränz M, Grünewald C, Brüß S, Krstić I, Prisner T F, Heckel A, Göbel M W, authors. Eur J Org Chem. 2014;4037–4043. [Cross Ref]

Weinrich T, Gränz M, Grünewald C, Prisner T F, Göbel M W, authors. Eur J Org Chem. 2017;491–496. [Cross Ref]

Weinrich T, Jaumann E A, Scheffer U, Prisner T F, Göbel M W, authors. Chem – Eur J. 2018;24:6202–6207. [Cross Ref] [PubMed]

Heckel A, Buff M C R, Raddatz M-S L, Müller J, Pötzsch B, Mayer G, authors. Angew Chem, Int Ed. 2006;45:6748–6750. [Cross Ref]

Wenter P, Pitsch S, authors. Helv Chim Acta. 2003;86:3955–3974. [Cross Ref]

Bhattarai S, Freundlieb M, Pippel J, Meyer A, Abdelrahman A, Fiene A, Lee S-Y, Zimmermann H, Yegutkin G G, Sträter N, et al., authors. J Med Chem. 2015;58:6248–6263. [Cross Ref] [PubMed]

Zadeh J N, Steenberg C D, Bois J S, Wolfe B R, Pierce M B, Khan A R, Dirks R M, Pierce N A, authors. J Comput Chem. 2011;32:170–173. [Cross Ref] [PubMed]

Jeschke G, Chechik V, Ionita P, Godt A, Zimmermann H, Banham J, Timmel C R, Hilger D, Jung H, authors. Appl Magn Reson. 2006;30:473–498. [Cross Ref]

Sato Y, Hayashi H, Okazaki M, Aso M, Karasawa S, Ueki S, Suemune H, Koga N, authors. Magn Reson Chem. 2008;46:1055–1058. [Cross Ref] [PubMed]

[Back]

Figure 1.

Structures of TEMPO-labeled oligonucleotides and of phosphoramidites 5–8.

[Back]

[Back]

Scheme 1.

Synthesis of phosphoramidite 5. Reagents and conditions: (a) 1. 2,4,6-triisopropylbenzenesulfonyl chloride, Et₃N, 4-dimethylaminopyridine, CH₂Cl₂, 0 °C → rt, 19 h; 2. addition of 10, diisopropylethylamine, DMF, 90 °C, 24 h; (b) MeOH, NaHCO₃, rt, 2.5 h; (c) N,N-diisopropylamino(2-cyanoethyl)phosphoramidic chloride, Et₃N, CH₂Cl₂, rt, 20 h.

[Back]

[Back]

Scheme 2.

Synthesis of phosphoramidite 7. Reagents and conditions: (a) Addition of 10, diisopropylethylamine, 1-propanol, 75 °C, 8 h, rt, 14 h; (b) 7 N NH₃ in MeOH, 0 °C → rt, 3 h; (c) dimethoxytrityl chloride, pyridine, rt, 23 h; (d) N,N-diisopropylamino(2-cyanoethyl)phosphoramidic chloride, Et₃N, CH₂Cl₂, rt, 4.5 h.

[Back]

[Back]

Scheme 3.

Synthesis of phosphoramidite 8. Reagents and conditions: (a) Addition of 10, diisopropylethylamine, 1-propanol, 75 °C, 7 h, rt, 14 h; (b) 7 N NH₃ in MeOH, 0 °C → rt, 3 h; (c) dimethoxytrityl chloride, pyridine, rt, 20 h; (d) tert-butyldimethylsilyl chloride, imidazole, DMF, rt, 22 h; (e) N,N-diisopropylamino(2-cyanoethyl)phosphoramidic chloride, Et₃N, CH₂Cl₂, rt, 23 h.

[Back]

[Back]

Figure 2.

Structures of palindromic oligonucleotides prepared from amidites 5 (22a, 23a), 7 (24a, 25a), and 8 (26a, 27a). Hemiacetals 22b–27b were obtained after photochemical deprotection (custom built apparatus with three LEDs Nichia NCCU033, 365 nm, each with 100 mW optical output power [41]. 20 min irradiation in 10 mM phosphate buffer, pH 7.4). Subsequent elimination of formic aldehyde and air oxidation transformed these intermediates into nitroxides 22c–27c. Amines 22d–27d, typical degradation products of nitroxides, could not be detected.

[Back]

[Back]

Figure 3.

PELDOR measurement of 24c (12mer dA). The background-corrected time trace (original time trace in Supporting Information File 1, Figure S21) was fitted with Tikhonov regularization (red) with DeerAnalysis15 [48]. The distance distribution shows a well-defined distance of 2.9 ± 0.2 nm.

[Back]

[Back]

Table 1.

Spin–spin distances in oligonucleotides 22c–27c determined by PELDOR and by molecular modelling. The predicted distance is an average of N–N, N–O, O–N, and O–O distances.

sample
PELDOR
simulation

22c
2.5 ± 0.2 nm
2.6 nm

24c
2.9 ± 0.2 nm
3.0 nm

26c
2.5 ± 0.2 nm
2.5 nm

23c
4.1 ± 0.2 nm
4.3 nm

25c
4.9 ± 0.2 nm
5.0 nm

27c
4.1 ± 0.2 nm
4.0 nm

[Back]